{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:25:06Z","timestamp":1790364306067,"version":"4.1.0"},"reference-count":65,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"659","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2022,8,24]]},"abstract":"<jats:p>Understanding the build-up of immunity with successive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the epidemiological conditions that favor rapidly expanding epidemics will help facilitate future pandemic control. We analyzed high-resolution infection and serology data from two longitudinal household cohorts in South Africa to reveal high cumulative infection rates and durable cross-protective immunity conferred by prior infection in the pre-Omicron era. Building on the history of past exposures to different SARS-CoV-2 variants and vaccination in the cohort most representative of South Africa\u2019s high urbanization rate, we used mathematical models to explore the fitness advantage of the Omicron variant and its epidemic trajectory. Modeling suggests that the Omicron wave likely infected a large fraction (44 to 81%) of the population, leaving a complex landscape of population immunity primed and boosted with antigenically distinct variants. We project that future SARS-CoV-2 resurgences are likely under a range of scenarios of viral characteristics, population contacts, and residual cross-protection.<\/jats:p>","DOI":"10.1126\/scitranslmed.abo7081","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T09:58:36Z","timestamp":1653991116000},"source":"Crossref","is-referenced-by-count":49,"title":["SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron\u2019s impact in South African population cohorts"],"prefix":"10.1126","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-9884","authenticated-orcid":true,"given":"Kaiyuan","family":"Sun","sequence":"first","affiliation":[{"name":"Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD 20892-2220, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-347X","authenticated-orcid":true,"given":"Stefano","family":"Tempia","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."},{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-6273","authenticated-orcid":true,"given":"Jackie","family":"Kleynhans","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-7455","authenticated-orcid":true,"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2000, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-4033","authenticated-orcid":true,"given":"Meredith L.","family":"McMorrow","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9526-0133","authenticated-orcid":true,"given":"Nicole","family":"Wolter","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2000, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-4003","authenticated-orcid":true,"given":"Jinal N.","family":"Bhiman","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2000, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-1717","authenticated-orcid":true,"given":"Jocelyn","family":"Moyes","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon","family":"du Plessis","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2000, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2717-5540","authenticated-orcid":true,"given":"Maimuna","family":"Carrim","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2000, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Buys","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Martinson","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, 1864, South Africa."},{"name":"Johns Hopkins University Center for TB Research, Baltimore, MD, 21287, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-3931","authenticated-orcid":true,"given":"Kathleen","family":"Kahn","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0744-7588","authenticated-orcid":true,"given":"Stephen","family":"Tollman","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-0573","authenticated-orcid":true,"given":"Limakatso","family":"Lebina","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, 1864, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1300-7490","authenticated-orcid":true,"given":"Floidy","family":"Wafawanaka","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-0168","authenticated-orcid":true,"given":"Jacques D.","family":"du Toit","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4876-0848","authenticated-orcid":true,"given":"Francesc Xavier","family":"G\u00f3mez-Oliv\u00e9","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-0358","authenticated-orcid":true,"given":"Thulisa","family":"Mkhencele","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3243-4711","authenticated-orcid":true,"given":"C\u00e9cile","family":"Viboud","sequence":"additional","affiliation":[{"name":"Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD 20892-2220, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-2302","authenticated-orcid":true,"given":"Cheryl","family":"Cohen","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, 2131, South Africa."},{"name":"School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe9728"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2802.211689"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-051836"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00069-X"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01255-3"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03402-9"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04411-y"},{"key":"e_1_3_3_9_2","article-title":"Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa","author":"Pearson C. A. B.","year":"2021","unstructured":"C. A. B. Pearson, S. P. Silal, M. W. Z. Li, J. Dushoff, B. M. Bolker, S. Abbott, C. van Schalkwyk, N. G. Davies, R. C. Barnard, W. J. Edmunds, J. Bingham, G. Meyer-Rath, L. Jamieson, A. Glass, N. Wolter, N. Govender, W. S. Stevens, L. Scott, K. Mlisana, H. Moultrie, J. R. C. Pulliam, Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa. bioRxiv 10.1101\/2021.12.19.21268038, (2021).","journal-title":"bioRxiv"},{"key":"e_1_3_3_10_2","unstructured":"A. A. Latif J. L. Mullen M. Alkuzweny G. Tsueng M. Cano E. Haag J. Zhou M. Zeller E. Hufbauer N. Matteson C. Wu K. G. Andersen A. I. Su K. Gangavarapu L. D. Hughes and the Center for Viral Systems Biology Omicron Variant Report. outbreak.info (2022); https:\/\/outbreak.info\/situation-reports\/omicron?loc=ZAF&loc=GBR&loc=USA&selected=ZAF."},{"key":"e_1_3_3_11_2","unstructured":"the Nextstrain team Genomic epidemiology of novel coronavirus - Global subsampling (Nextstrain 2022); https:\/\/nextstrain.org\/ncov\/gisaid\/global."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4947"},{"key":"e_1_3_3_13_2","unstructured":"N. Ferguson A. Ghani A. Cori A. Hogan W. Hinsley Erik Volz on behalf of the Imperial College COVID-19 response team Report 49 - Growth Population Distribution and Immune Escape of Omicron in England (MRC Centre for Global Infectious Disease Analysis Imperial College London 2021; www.imperial.ac.uk\/mrc-global-infectious-disease-analysis\/covid-19\/report-49-omicron\/)."},{"key":"e_1_3_3_14_2","article-title":"Mapping the antigenic diversification of SARS-CoV-2","author":"van der Straten K.","year":"2022","unstructured":"K. van der Straten, D. Guerra, M. J. van Gils, I. Bontjer, T. G. Caniels, H. D. G. van Willigen, E. Wynberg, M. Poniman, J. A. Burger, J. H. Bouhuijs, J. van Rijswijk, A. H. A. Lavell, B. Appelman, J. J. Sikkens, M. K. Bomers, A. X. Han, B. E. Nichols, M. Prins, H. Vennema, C. Reusken, M. D. de Jong, G. J. de Bree, C. A. Russell, D. Eggink, R. W. Sanders, Mapping the antigenic diversification of SARS-CoV-2. bioRxiv 10.1101\/2022.01.03.21268582, (2022).","journal-title":"bioRxiv"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04387-1"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04399-5"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04386-2"},{"key":"e_1_3_3_18_2","unstructured":"UKHSA Genomics Cell UKHSA Outbreak Surveillance Team UKHSA Epidemiology Cell UKHSA Immunisations Team UKHSA Contact Tracing Data Team UKHSA Environmental Monitoring for Health Protection Team UKHSA SIREN Study Team UKHSA Public Health Incident Directors Contributions from the Variant Technical Group Members SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 34 ( UK Health Security Agency 2022; https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1046853\/technical-briefing-34-14-january-2022.pdf)."},{"key":"e_1_3_3_19_2","article-title":"SARS-CoV-2 Omicron VOC transmission in Danish households","author":"Lyngse F. P.","year":"2021","unstructured":"F. P. Lyngse, L. H. Mortensen, M. J. Denwood, L. E. Christiansen, C. H. M\u00f8ller, R. L. Skov, K. Spiess, A. Fomsgaard, M. M. Lassauni\u00e8re, M. Rasmussen, M. Stegger, C. Nielsen, R. N. Sieber, A. S. Cohen, F. T. M\u00f8ller, M. Overvad, K. M\u00f8lbak, T. G. Krause, C. T. Kirkeby, SARS-CoV-2 Omicron VOC transmission in Danish households. bioRxiv 10.1101\/2021.12.27.21268278, (2021).","journal-title":"bioRxiv"},{"key":"e_1_3_3_20_2","article-title":"Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study, Ontario, Canada","author":"Ulloa A. C.","year":"2022","unstructured":"A. C. Ulloa, S. A. Buchan, N. Daneman, K. A. Brown, Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study, Ontario, Canada. bioRxiv 10.1101\/2021.12.24.21268382, (2022).","journal-title":"bioRxiv"},{"key":"e_1_3_3_21_2","unstructured":"WEEKLY EPIDEMIOLOGICAL BRIEF - NICD (2020); www.nicd.ac.za\/diseases-a-z-index\/disease-index-covid-19\/surveillance-reports\/weekly-epidemiological-brief\/."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001333"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi5273"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.6.2200042"},{"key":"e_1_3_3_25_2","unstructured":"National Institute of Infectious Diseases Disease Control and Prevention Center National Center for Global Health and Medicine Active epidemiological investigation on SARS-CoV-2 infection caused by Omicron variant (Pango lineage B.1.1.529) in Japan: Preliminary report on infectious period \u56fd\u7acb\u611f\u67d3\u75c7\u7814\u7a76\u6240 (2022; www.niid.go.jp\/niid\/en\/2019-ncov-e\/10884-covid19-66-en.html."},{"key":"e_1_3_3_26_2","article-title":"The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism","author":"Willett B. J.","year":"2022","unstructured":"B. J. Willett, J. Grove, O. A. MacLean, C. Wilkie, N. Logan, G. D. Lorenzo, W. Furnon, S. Scott, M. Manali, A. Szemiel, S. Ashraf, E. Vink, W. Harvey, C. Davis, R. Orton, J. Hughes, P. Holland, V. Silva, D. Pascall, K. Puxty, A. da Silva Filipe, G. Yebra, S. Shaaban, M. T. G. Holden, R. M. Pinto, R. Gunson, K. Templeton, P. Murcia, A. H. Patel; The COVID-19 Genomics UK (COG-UK) Consortium, J. Haughney, D. L. Robertson, M. Palmarini, S. Ray, E. C. Thomson, The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. bioRxiv 10.1101\/2022.01.03.21268111, (2022).","journal-title":"bioRxiv"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.060"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2712.211465"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119236"},{"key":"e_1_3_3_30_2","article-title":"Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant","author":"Khan K.","year":"2021","unstructured":"K. Khan, F. Karim, S. Cele, J. E. San, G. Lustig, H. Tegally, M. Bernstein, Y. Ganga, Z. Jule, K. Reedoy, N. Ngcobo, M. Mazibuko, N. Mthabela, Z. Mhlane, N. Mbatha, J. Giandhari, Y. Ramphal, T. Naidoo, N. Manickchund, N. Magula, S. S. Abdool Karim, G. Gray, W. Hanekom, A. von Gottberg, R. Milo, B. I. Gosnell, R. J. Lessells, P. L. Moore, T. de Oliveira, M.-Y. S. Moosa, A. Sigal, Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant. medRxiv 10.1101\/2021.12.27.21268439, (2021).","journal-title":"medRxiv"},{"key":"e_1_3_3_31_2","article-title":"Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant","author":"Altarawneh H.","year":"2022","unstructured":"H. Altarawneh, H. Chemaitelly, P. Tang, M. R. Hasan, S. Qassim, H. H. Ayoub, S. AlMukdad, H. M. Yassine, F. M. Benslimane, H. A. A. Khatib, P. Coyle, Z. A. Kanaani, E. A. Kuwari, A. Jeremijenko, A. H. Kaleeckal, A. N. Latif, R. M. Shaik, H. F. Abdul Rahim, G. K. Nasrallah, M. G. Al Kuwari, A. A. Butt, H. E. Al Romaihi, M. H. Al-Thani, A. A. Khal, R. Bertollini, L. J. Abu-Raddad, Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant. bioRxiv, (2022).","journal-title":"bioRxiv"},{"key":"e_1_3_3_32_2","article-title":"Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021","author":"Hall V. J.","year":"2021","unstructured":"V. J. Hall, S. Foulkes, F. Insalata, A. Saei, P. Kirwan, A. Atti, E. Wellington, J. Khawam, K. Munro, M. Cole, C. Tranquillini, A. Taylor-Kerr, N. Hettiarachchi, D. Calbraith, N. Sajedi, I. Milligan, Y. Themistocleous, D. Corrigan, L. Cromey, L. Price, S. Stewart, E. de Lacy, C. Norman, E. Linley, A. D. Otter, A. Semper, J. Hewson, S. D\u2019Arcangelo; The SIREN Study Group, M. A. Chand, C. S. Brown, T. Brooks, J. Islam, A. Charlett, S. Hopkins, Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021. medRxiv 10.1101\/2021.11.29.21267006, (2021).","journal-title":"medRxiv"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00575-4"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00678-4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","article-title":"Effectiveness of a third dose of mRNA vaccines against COVID-19\u2013associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance\u2014VISION Network, 10 States, August 2021\u2013January 2022","volume":"71","author":"Thompson M. G.","year":"2022","unstructured":"M. G. Thompson, K. Natarajan, S. A. Irving, E. A. Rowley, E. P. Griggs, M. Gaglani, N. P. Klein, S. J. Grannis, M. B. DeSilva, E. Stenehjem, S. E. Reese, M. Dickerson, A. L. Naleway, J. Han, D. Konatham, C. M. Evoy, S. Rao, B. E. Dixon, K. Dascomb, N. Lewis, M. E. Levy, P. Patel, I.-C. Liao, A. B. Kharbanda, M. A. Barron, W. F. Fadel, N. Grisel, K. Goddard, D.-H. Yang, M. H. Wondimu, K. Murthy, N. R. Valvi, J. Arndorfer, B. Fireman, M. M. Dunne, P. Embi, E. Azziz-Baumgartner, O. Zerbo, C. H. Bozio, S. Reynolds, J. Ferdinands, J. Williams, R. Link-Gelles, S. J. Schrag, J. R. Verani, S. Ball, T. C. Ong, Effectiveness of a third dose of mRNA vaccines against COVID-19\u2013associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance\u2014VISION Network, 10 States, August 2021\u2013January 2022. MMWR Morb. Mortal. Wkly. Rep. 71, 139\u2013145 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_3_36_2","article-title":"Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California","author":"Lewnard J. A.","year":"2022","unstructured":"J. A. Lewnard, V. X. Hong, M. M. Patel, R. Kahn, M. Lipsitch, S. Y. Tartof, Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California. medRxiv 10.1101\/2022.01.11.22269045, (2022).","journal-title":"medRxiv"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00141-8"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307506101"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab543"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107058"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01316-7"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100150"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa310"},{"key":"e_1_3_3_44_2","unstructured":"The National Institute For Communicable Diseases Of South Africa NICD National COVID-19 Hospital Surveillance (The National Institute For Communicable Diseases Of South Africa 2022; www.nicd.ac.za\/wp-content\/uploads\/2022\/02\/NICD-COVID-19-Daily-Sentinel-Hospital-Surveillance-report-National-20220203.pdf)."},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00017-4"},{"key":"e_1_3_3_46_2","unstructured":"South Africa National Department Of Health Latest Vaccine Statistics (South Africa) SA Corona Virus Online Portal (2021); https:\/\/sacoronavirus.co.za\/latest-vaccine-statistics\/."},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04060-7"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.07.008"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03738-2"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj9853"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20544-y"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6810"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12881"},{"key":"e_1_3_3_56_2","unstructured":"Elecsys\u00ae Anti-SARS-CoV-2 (2022); https:\/\/diagnostics.roche.com\/us\/en\/products\/params\/elecsys-anti-sars-cov-2.html."},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh3409"},{"key":"e_1_3_3_58_2","unstructured":"CDC Frequently Asked Questions about Coronavirus (COVID-19) for Laboratories (2021); www.cdc.gov\/coronavirus\/2019-ncov\/lab\/faqs.html."},{"key":"e_1_3_3_59_2","unstructured":"Public Health England Cycle threshold (Ct) in SARS-CoV-2 RT-PCR (2020); www.gov.uk\/government\/publications\/cycle-threshold-ct-in-sars-cov-2-rt-pcr."},{"key":"e_1_3_3_60_2","article-title":"Transmission dynamics and epidemiological characteristics of Delta variant infections in China","author":"Kang M.","year":"2021","unstructured":"M. Kang, H. Xin, J. Yuan, S. T. Ali, Z. Liang, J. Zhang, T. Hu, E. H. Y. Lau, Y. Zhang, M. Zhang, B. J. Cowling, Y. Li, P. Wu, Transmission dynamics and epidemiological characteristics of Delta variant infections in China. medRxiv 10.1101\/2021.08.12.21261991, (2021).","journal-title":"medRxiv"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529982"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1981.10477634"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69302"},{"key":"e_1_3_3_64_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox D. R.","year":"1972","unstructured":"D. R. Cox, Regression models and life-tables. J. R. Stat. Soc. B Stat. Methodol. 34, 187\u2013220 (1972).","journal-title":"J. R. Stat. Soc. B Stat. Methodol."},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i01"},{"key":"e_1_3_3_66_2","first-page":"w20224","article-title":"Potential impact of seasonal forcing on a SARS-CoV-2 pandemic","volume":"150","author":"Neher R. A.","year":"2020","unstructured":"R. A. Neher, R. Dyrdak, V. Druelle, E. B. Hodcroft, J. Albert, Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Med. Wkly. 150, w20224 (2020).","journal-title":"Swiss Med. Wkly."}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.abo7081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:52:54Z","timestamp":1727311974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abo7081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":65,"journal-issue":{"issue":"659","published-print":{"date-parts":[[2022,8,24]]}},"alternative-id":["10.1126\/scitranslmed.abo7081"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.abo7081","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.11.22270854","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"article-number":"eabo7081"}}